Free Trial
NASDAQ:YI

111 Q2 2025 Earnings Report

111 logo
$5.22 -0.20 (-3.69%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$5.24 +0.02 (+0.31%)
As of 09/19/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

111 EPS Results

Actual EPS
-$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$447.51 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

111 Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

111 Earnings Headlines

111 (NASDAQ:YI) Given Sell (D-) Rating at Weiss Ratings
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update
111 Inc Share Price | NASDAQ: YI Stock - Investing.com UK
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc. aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc.’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods. The platform offers specialized services for prescription fulfillment, enabling users to upload medical prescriptions securely and receive licensed medications through certified pharmacy partners. In addition to its core pharmaceutical offerings, the company features a curated selection of imported wellness and beauty brands sourced from markets such as the United States, Europe, and Japan.

With a focus on cross-border e-commerce, 111, Inc. partners with domestic manufacturers and international suppliers to ensure product authenticity and quality control. The company operates strategically located warehouses to facilitate efficient order processing and delivery, leveraging both direct shipping from overseas distributors and local inventory hubs. Its digital infrastructure supports real-time inventory tracking, customer support, and data-driven recommendations to enhance the consumer experience.

Founded in 2010 and headquartered in Shanghai, 111, Inc. has grown alongside China’s expanding digital healthcare market. Its management team brings together expertise in online retail, supply chain logistics, and regulatory compliance to navigate the complexities of pharmaceutical distribution. Through ongoing platform enhancements and strategic partnerships, 111, Inc. continues to expand its reach and service offerings in China’s rapidly evolving healthcare e-commerce landscape.

View 111 Profile

More Earnings Resources from MarketBeat